Details for New Drug Application (NDA): 011161
✉ Email this page to a colleague
NDA 011161 describes ARISTOCORT, which is a drug marketed by Astellas and Fosun Pharma and is included in fourteen NDAs. Additional details are available on the ARISTOCORT profile page.
The generic ingredient in ARISTOCORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.
The generic ingredient in ARISTOCORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.
Summary for 011161
| Tradename: | ARISTOCORT |
| Applicant: | Astellas |
| Ingredient: | triamcinolone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011161
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 009
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
